Drawing for MANTEIA

USPTO serial 76458853

MANTEIA

Reviewed by CopyMark Law Group

Reg. 2930025Status 710
Filing date
Status date
Registration date
Mar 8, 2005
Examiner
ESTRADA, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MANTEIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert B.G. Horowitz, Esq.

Robert B.G. Horowitz, Esq. Baker & Hostetler LLP45 Rockefeller PlazaNew York, NY 10111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001DIAGNOSTIC PRODUCTS, NAMELY, DNA SEQUENCES FOR SCIENTIFIC USE; DIAGNOSTIC TEST KITS FOR SCIENTIFIC USE COMPRISED PRIMARILY OF REAGENTS, PROCESSING CHEMICALS, SLIDES, AND PATCHESSECTION 8 - CANCELLED—
005PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS, PREPARATIONS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF NECROLOGICAL AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL AND CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF REPRODUCTIVE HEALTH DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF ENDOCRINOLOGY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH AGING, PREPARATIONS FOR THE TREATMENT OF NEONATAL RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS; PREPARATIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DIABETES, PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR AND CIRCULATORY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF GASTROENTEROLOGICAL DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF GROWTH HORMONE DEFICIENCY DISEASES AND DISORDERS,PREPARATIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DNA AND/OR RNA (DEOXYRIBONUCLEIC ACID AND RIBONUCLEIC ACID) DISORDERS AND FOR THE TREATMENT OF DISEASES RELATED TO DNA AND/OR RNA DISORDERSSECTION 8 - CANCELLED—
009MAGNETIC AND OPTICAL DATA CARRIERS PRE-RECORDED WITH MEDICAL AND GENETIC INFORMATION FOR USE IN MEDICAL APPLICATIONS; COMPUTER SOFTWARE FOR CONTROLLING DATA FROM MEDICAL EQUIPMENT RELATING TO GENETIC, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS; SEQUENCERS FOR DETERMINING THE NUCLEAC ACID CONTENT OF BIOLOGICAL SAMPLES; COMPUTER SOFTWARE FOR DISPLAYING GRAPHS IN GENOMIC RESEARCH, GENETIC ASSOCIATION STUDIES AND PRODUCT DEVELOPMENTSECTION 8 - CANCELLED—
010MEDICAL EQUIPMENT, NAMELY, DNA AND RNA ANALYSIS APPARATUS COMPRISING A DEVICE TO EXTRACT NUCLEIC ACIDS FROM BIOLOGICAL SAMPLES, A DEVICE FOR CONVERTING THE NUCLEIC ACIDS TO DNA, A DEVICE FOR SEQUENCING THE ISOLATED DNA, COMPUTER HARDWARE AND COMPUTER SOFTWARE FOR CONTROLLING OR OPERATING THE MEDICAL EQUIPMENT FOR DETERMINING DISEASE PREDISPOSITION AND RESPONSE TO MEDICAL TREATMENT, FOR USE IN GENETIC ASSOCIATION STUDIES, FOR USE IN GENOME MAPPING, FOR USE IN GENOME ANALYSIS, FOR USE IN GENOME SCANNING, FOR USE IN GENE EXPRESSION LEVEL MONITORING, FOR USE IN DETERMINING NUCLEIC ACID COMPOSITION OF BIOLOGICAL SAMPLES, FOR USE IN GENOME SEQUENCING, ALL FOR HUMAN AND VETERINARY MEDICAL PURPOSES; DIAGNOSTIC EQUIPMENT FOR MEDICAL USE, NAMELY, COMPUTERS AND PRINTERS USED FOR THE ANALYSIS, INTERPRETATION AND DISPLAY OF DIAGNOSTIC TESTS AND TEST RESULTSSECTION 8 - CANCELLED—
042BIOTECHNOLOGY RESEARCH AND DEVELOPMENT SERVICES FOR OTHERS, NAMELY, GENETIC ASSOCIATION STUDIES, GENOME MAPPING, GENOME ANALYSIS, GENOME SCANNING, GENE EXPRESSION LEVEL MONITORING, NUCLEIC ACID COMPOSITION OF SCANNING, GENE EXPRESSION LEVEL MONITORING, NUCLEIC ACID COMPOSITION OF BIOLOGICAL SAMPLES GENOME SEQUENCING, ECOSYSTEM SEQUENCING, DRUG AND THERAPEUTIC PREPARATIONS DEVELOPMENT, AND CONSULTATION IN THE FIELD OF GENOMICS AND DRUG DEVELOPMENT; SCIENTIFIC RESEARCH IN THE NATURE OF DNA SEQUENCINGSECTION 8 - CANCELLED—
044PHARMACEUTICAL ADVICE; HEALTH CARE, MEDICAL ASSISTANCE, NAMELY, DIAGNOSTIC AND PROGNOSTIC ADVICE IN THE SELECTION OF TREATMENT AND IN THE PREVENTIVE AND PREDICTIVE MEDICINE FIELDS; HOSPITALS; BLOOD BANK SERVICES; PLASTIC SURGERY; ARTIFICIAL INSEMINATION SERVICES; IN VITRO FERTILIZATION SERVICES; VETERINARY ASSISTANCE; ANIMAL BREEDING; WEED KILLINGSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)—
Apr 29, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 23, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 14, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 24, 2004NPUBNOTICE OF PUBLICATION—
Oct 6, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 1, 2004ALIEASSIGNED TO LIE—
Sep 30, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2004XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2004CNEAEXAMINERS AMENDMENT MAILED—
Sep 28, 2004CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 29, 2004XAECEXAMINER'S AMENDMENT ENTERED—
Jun 28, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 27, 20041.BDSec. 1(B) CLAIM DELETED—
May 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2004MAILPAPER RECEIVED—
Nov 26, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2003CFITCASE FILE IN TICRS—
Aug 25, 2003MAILPAPER RECEIVED—
Aug 20, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance